Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jesse Manunga

Vascular Surgery Minneapolis, MN Medical Doctor

NPI 1376730093 CMS profile 516407

920 E 28Th St, Suite 300, Minneapolis, MN 55407

Open in the dashboard

General payments

$94,618

234 records reported · program years 2019–2025

Research payments

$3,822

Paid to them · 7 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$50,096 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Jesse Manunga of Minneapolis, MN is reported in the CMS Open Payments database as having received $94,618 across 234 general payments and $3,822 in research payments paid to them. Separately, studies naming them as principal investigator received $50,096 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $34,085 62
2024 General $16,757 29
2023 General $9,090 27
2022 General $8,120 32
2022 Research $936 2
2021 General $624 8
2021 Research $936 2
2020 General $10,895 23
2020 Research $1,950 3
2019 General $15,047 53

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jesse Manunga
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Jesse Manunga were reported at $34,085. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Jesse Manunga Vascular Surgery median Middle half National median
2019 $15,047 $796 $226–$2,363 $163
2020 $10,895 $348 $118–$1,110 $114
2021 $624 $471 $158–$1,421 $132
2022 $8,120 $725 $222–$2,183 $149
2023 $9,090 $836 $257–$2,440 $160
2024 $16,757 $909 $252–$2,619 $164
2025 $34,085 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $61,985 104 payments
  2. Medtronic USA, Inc. $24,703 38 payments
  3. W. L. Gore & Associates, Inc. $4,019 31 payments
  4. Cook Medical LLC $2,516 47 payments
  5. Bolton Medical Inc $416 5 payments
  6. Medtronic Vascular, Inc. $314 3 payments
  7. Ge Healthcare $303 2 payments
  8. Boston Scientific Corporation $157 2 payments
  9. Bard Peripheral Vascular, Inc. $128 1 payment
  10. Silk Road Medical, Inc. $77 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $68,373 20 payments
  2. Travel and Lodging $15,310 68 payments
  3. Food and Beverage $8,194 142 payments
  4. Consulting Fee $2,740 4 payments
Products named General payments · program years 2019–2025
  1. PIVOX Oblique Lateral Spinal System Tl $38,483 51 payments
  2. PIVOX Oblique Lateral Spinal System Tl $24,327 35 payments
  3. CD HORIZON SPINAL SYSTEM $11,760 27 payments
  4. MAZOR X SYSTEM $4,147 6 payments
  5. GORE TAG Thoracic Branch Endoprosthesis $2,567 7 payments
  6. GORE TAG Conformable Thoracic Stent Graft $2,292 4 payments
  7. SOVEREIGN SPINAL SYSTEM $2,000 1 payment
  8. Zenith Alpha Aortic Intervention $974 8 payments
  9. ZENITH ALPHA Aortic Intervention $550 6 payments
  10. UNID_PASS $483 2 payments
  11. Other $5,893 90 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Cook Research Incorporated $3,822 7 payments

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

45

Median for Vascular Surgery: 122

Drug cost

$211

Median for Vascular Surgery: $14,135

Branded share of claims

73.3%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clopidogrel Clopidogrel Bisulfate Brand 33 $196
Prednisone Generic 12 $15

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 73 billing codes

Paid by Medicare

$111,442

Medicare's payments for the services billed

Medicare patients

339

Average age 75

Services billed

656

162 women, 177 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 51%
Arthritis 48%
Diabetes 40%
Chronic kidney disease 34%
Heart failure 27%
Atrial fibrillation 25%
Depression 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

241 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record